NCT03694626 is a NA clinical trial of Pupillography in Photophobia, sponsored by Randy Kardon.

Who is sponsoring NCT03694626?

NCT03694626 is sponsored by Randy Kardon.

What drugs are being tested in NCT03694626?

Interventions in NCT03694626: Pupillography, Ocular Coherence Tomography (OCT), Wrist-watch sensor device, Videography, Electrophysiology.

What condition does NCT03694626 study?

NCT03694626 studies Photophobia, Traumatic Brain Injury, Migraine.

Is NCT03694626 still recruiting?

NCT03694626 is currently recruiting now. Last updated 24 November 2025.

Last reviewed 2025-11-24 · How we verify

NCT03694626

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Objectively Diagnose and Monitor Treatment of Light Sensitivity

Recruiting now NA Last updated 24 November 2025

What this trial tests

NA trial testing Pupillography in Photophobia in 120 participants. Currently enrolling.

Timeline

11 July 2019

Primary endpoint
1 January 2028

1 January 2028

Quick facts

Lead sponsor	Randy Kardon
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	120
Start date	11 July 2019
Primary completion	1 January 2028
Estimated completion	1 January 2028
Sites	1 location across United States

Drugs / interventions tested

Pupillography
Ocular Coherence Tomography (OCT)
Wrist-watch sensor device
Videography
Electrophysiology

Conditions studied

Photophobia — all drugs for Photophobia →
Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
Migraine — all drugs for Migraine →

Sponsor

Randy Kardon

Who can join

Adults 18 to 80, any sex, with Photophobia or Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features, pupil responses, retinal electrical responses and autonomic nerve responses to light.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pupillography

Trials testing the same drug.

NCT03651661 — Pupillography as Screening Tool for Brain Insulin Resistance · NA · completed

Other recruiting trials for Photophobia

Currently open trials in the same condition.

NCT06905912 — Comparison Between Spectacles and Contact Lenses · NA · recruiting
NCT06109909 — Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury · NA · recruiting

Other Randy Kardon trials

Trials by the same sponsor.

NCT03475173 — New Non-invasive Modalities for Assessing Retinal Structure and Function · NA · recruiting
NCT03660618 — LSFG-SKIN, Laser Speckle Flowgraphy · NA · terminated
NCT03475147 — Smartphone Flicker Fusion Test for Patients With Optic Disorders. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03694626 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Randy Kardon
Last refreshed: 24 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03694626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing